The level of XPD mRNA expression in the tumour tissue of HNSCC patients decreased with increasing stage of cancer, as did the expression of XPD protein in the PBL of HNSCC patients which showed an overall significant decline to 77% of the level in PBL of controls. This evidence concerns the gene ERCC2 and cancer.